Abstract
We are concerned about the content and possible misinterpretation of a research letter by Le Moigne et al. published on 19 June 2017 in the British Journal of Dermatology online.[1]
We share the concern expressed by the authors about possible psychiatric effects of oral retinoids. However, case reports rank low in the hierarchy of evidence, as a result of their inherent limitations, including publication bias and a lack of control groups.
This article is protected by copyright. All rights reserved.
http://ift.tt/2GPAY1k
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου